Free Trial

Bone Biologics (BBLG) Short Interest Ratio & Short Volume

Bone Biologics logo
$2.33 -0.21 (-8.27%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$2.38 +0.05 (+2.36%)
As of 08/8/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bone Biologics Short Interest Data

Bone Biologics (BBLG) has a short interest of 46,200 shares, representing 2.89% of the float (the number of shares available for trading by the public). This marks a -91.14% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 60,053 shares to cover all short positions.

Current Short Interest
46,200 shares
Previous Short Interest
521,600 shares
Change Vs. Previous Month
-91.14%
Dollar Volume Sold Short
$133.98 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
550,000 shares
Float Size
1,600,000 shares
Short Percent of Float
2.89%
Today's Trading Volume
78,506 shares
Average Trading Volume
60,053 shares
Today's Volume Vs. Average
131%
Short Selling Bone Biologics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bone Biologics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BBLG Short Interest Over Time

BBLG Days to Cover Over Time

BBLG Percentage of Float Shorted Over Time

Bone Biologics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202546,200 shares $133.98 thousand -91.1%2.9%0.1 $2.90
6/30/2025521,600 shares $2.10 million +1,644.5%38.9%1.1 $4.03
6/15/202529,900 shares $141.58 thousand -10.2%33.6%0.9 $4.74
5/31/202533,300 shares $182.42 thousand -61.2%1.4%1.3 $5.48
5/15/202585,900 shares $62.65 thousand +18.7%16.1%0.5 $0.73
4/30/202572,400 shares $48.72 thousand -24.0%13.6%0.7 $0.67
4/15/202595,300 shares $68.62 thousand +6.0%17.9%0.6 $0.72
3/31/202589,900 shares $71.92 thousand +17.5%16.9%0.5 $0.80
3/15/202576,500 shares $63.50 thousand -60.4%14.3%0.4 $0.83
2/28/2025193,300 shares $171.79 thousand +48.2%36.2%0.9 $0.89
2/15/2025130,400 shares $135.62 thousand -15.9%24.5%0.6 $1.04
1/31/2025155,000 shares $172.05 thousand +105.0%29.1%0.8 $1.11
1/15/202575,600 shares $73.17 thousand +37.2%14.2%0.4 $0.97
12/31/202455,100 shares $51.81 thousand +9.8%10.3%0.2 $0.94
12/15/202450,200 shares $56.22 thousand -28.7%9.4%0.2 $1.12
11/30/202470,400 shares $85.89 thousand +21.0%13.2%0 $1.22
11/15/202458,200 shares $69.26 thousand -19.3%10.9%0 $1.19
10/31/202472,100 shares $97.34 thousand +48.4%13.8%0 $1.35
10/15/202448,600 shares $71.93 thousand -86.2%9.3%0 $1.48
9/30/2024352,700 shares $751.25 thousand +1,128.9%67.6%0.1 $2.13
9/15/202428,700 shares $22.96 thousand +129.6%5.5%0 $0.80
8/31/202412,500 shares $17.50 thousand -31.3%2.4%0 $1.40
8/15/202418,200 shares $26.75 thousand -89.5%3.5%0 $1.47
7/31/2024172,900 shares $373.46 thousand +3,162.3%33.6%0.1 $2.16
7/15/20245,300 shares $6.25 thousand +562.5%1.0%0 $1.18
6/30/2024800 shares $976.00 -96.3%0.2%0 $1.22
6/15/202421,800 shares $32.92 thousand +69.0%4.2%0.3 $1.51
5/31/202412,900 shares $21.41 thousand -29.5%2.5%0.2 $1.66
5/15/202418,300 shares $41.54 thousand -7.1%3.6%0.2 $2.27
4/30/202419,700 shares $30.76 thousand +51.5%3.9%0.2 $1.56
4/15/202413,000 shares $20.93 thousand -13.9%2.6%0.2 $1.61
3/31/202415,100 shares $32.16 thousand -51.5%3.1%0.2 $2.13
3/15/202431,100 shares $72.46 thousand -75.1%6.3%0.1 $2.33
2/29/2024124,800 shares $303.26 thousand +625.6%23.5%0.5 $2.43
2/15/202417,200 shares $66.22 thousand +65.4%3.2%0.1 $3.85
1/31/202410,400 shares $37.75 thousand -75.4%2.0%0 $3.63
1/15/202442,300 shares $178.51 thousand -25.7%8.0%0.1 $4.22
12/31/202356,900 shares $257.19 thousand +1,397.4%10.7%0.2 $4.52
12/15/20233,800 shares $11.52 thousand -92.6%1.1%0 $3.03
11/30/202351,600 shares $21.10 thousand +1,257.9%1.9%0.1 $0.41
Why AMZN, GOOG, MSFT might destroy NVDA (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/15/20233,800 shares $2.06 thousand -59.1%0.1%0 $0.54
10/31/20239,300 shares $4.87 thousand +121.4%0.3%0 $0.52
10/15/20234,200 shares $2.52 thousand -71.6%0.2%0 $0.60
9/30/202314,800 shares $10.51 thousand -35.1%0.5%0 $0.71
9/15/202322,800 shares $16.39 thousand +200.0%0.8%0.1 $0.72
8/31/20237,600 shares $5.15 thousand -29.6%0.3%0 $0.68
8/15/202310,800 shares $0.00 -57.0%0.4%0 $0.00

BBLG Short Interest - Frequently Asked Questions

What is Bone Biologics' current short interest?

Short interest is the volume of Bone Biologics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 46,200 shares of BBLG short. 2.89% of Bone Biologics' shares are currently sold short. Learn More on Bone Biologics' current short interest.

What is a good short interest percentage for Bone Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.89% of Bone Biologics' floating shares are currently sold short.

Is Bone Biologics' short interest increasing or decreasing?

Bone Biologics saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 46,200 shares, a drop of 91.1% from the previous total of 521,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bone Biologics' float size?

Bone Biologics currently has issued a total of 550,000 shares. Some of Bone Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bone Biologics currently has a public float of 1,600,000 shares.

How does Bone Biologics' short interest compare to its competitors?

2.89% of Bone Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Bone Biologics: Sharps Technology, Inc. (9.21%), Quoin Pharmaceuticals, Ltd. Sponsored ADR (1.56%), ENDRA Life Sciences Inc. (30.93%), Check-Cap Ltd. (0.44%), Venus Concept Inc. (4.13%), Tivic Health Systems, Inc. (2.64%), Aethlon Medical, Inc. (9.26%), GlucoTrack, Inc. (5.09%), LogicMark, Inc. (0.15%), Bluejay Diagnostics, Inc. (2.40%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Bone Biologics stock?

Short selling BBLG is an investing strategy that aims to generate trading profit from Bone Biologics as its price is falling. BBLG shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bone Biologics?

A short squeeze for Bone Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBLG, which in turn drives the price of the stock up even further.

How often is Bone Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBLG, twice per month. The most recent reporting period available is July, 15 2025.




This page (NASDAQ:BBLG) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners